Browsing: Clearance

FDA clears ENV-308 for Phase 1 as Enveda doses first patient and appoints former Novo Nordisk executive to lead metabolic…

FDA greenlights early-stage trial of VectorY’s first-in-class therapy targeting the core biology driving most ALS cases. Netherlands-based biotech VectorY Therapeutics…

People with memory or thinking changes who are worried they have Alzheimer’s disease can get an answer sooner thanks to…

Process characterization and viral clearance validation are pivotal studies in biopharmaceutical manufacturing, particularly for monoclonal antibodies (mAb) produced in mammalian…

Company advances candidate targeting senescent cells into US study with potential applications beyond dermatology. Rubedo Life Sciences has announced that…